Cytotherapy is the Official Journal of the International Society for Cellular Therapy (ISCT).
Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, physicians, and regulatory experts involved in cell processing and therapy.
The journal's scope includes research in:
- Stem cell processing and transplantation
- Cell-based therapies of malignant and non-malignant blood diseases
- Stem cell plasticity
- Autoimmune diseases
- Congenital disorders
- Novel molecular therapies
- Gene therapy
- Microvesicle biology and therapeutic application
Readership and Target Group: Cytotherapy provides essential reading for scientists, physicians, technicians and regulatory experts involved in cell processing and therapy. It is a vital resource for hematologists, oncologists, and immunologists and the growing number of physicians from many disciplines involved in tissue repair and stem cell research, cytokine investigators, cancer biologists and biotherapists.
Keywords: Cytotherapy, Cytokine, Translational Research, Stem Cells, Cellular Therapies, Vaccines, Gene Therapy, Immunotherapy, Tissue Engineering, Blood and Bone Marrow, T cells.
Submission Details: Cytotherapy publishes original papers, reviews, novel hypotheses, short communications, book reviews and editorials. Submitted manuscripts will be reviewed by at least two reviewers. Authors will be notified within 30 working days of receipt, whether the manuscript is accepted, requires revision, or is rejected. All manuscripts will be published within 5 months from the date of acceptance. Contributors should submit manuscripts via: http://mc.manuscriptcentral.com/cytotherapy.
For advertising information, please contact:
Elsevier Inc., Cambridge, MA, USA
Tel: +1 617 397 2893